Optimized MRI of Patients With Hip Arthroplasty

Description

This is a single-center single-arm clinical trial with a paired design which compares the effectiveness of 3T MRI with (modified) and without (standard) radiofrequency pulse polarization optimization in reducing metal-related artifacts in patients with hip arthroplasty implants.

Conditions

Hip Arthropathy

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a single-center single-arm clinical trial with a paired design which compares the effectiveness of 3T MRI with (modified) and without (standard) radiofrequency pulse polarization optimization in reducing metal-related artifacts in patients with hip arthroplasty implants.

Optimized MRI of Patients With Hip Arthroplasty

Optimized MRI of Patients With Hip Arthroplasty

Condition
Hip Arthropathy
Intervention / Treatment

-

Contacts and Locations

New York

NYU Langone Radiology - Center for Biomedical Imaging, New York, New York, United States, 10017

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients aged ≥ 18 with unilateral symptomatic (e.g. pain) total hip arthroplasty
  • * Referred for MRI examination at the discretion of the treating physician
  • * Provision of signed and dated informed consent form
  • * No metal hardware in the body including contralateral hip arthroplasty
  • * No contraindication to MRI: defined as claustrophobia or presence of other MRI-incompatible devices
  • * History of revision hip arthroplasty
  • * Pregnancy (self-reported, or self-suspected)
  • * Hip arthroplasty surgery within one year of enrollment
  • * Clinical indication to administer intravenous contrast material during MRI

Ages Eligible for Study

18 Years to 99 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

NYU Langone Health,

Iman Khodarahmi, MD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

2025-12-30